DXC (DXC) insurance software unit sale could fetch around USD 2.4bln, according to reports

DXC (DXC) insurance software unit sale could fetch around USD 2.4bln, according to reports.

Carve-out speculation of this kind follows a familiar sequence: an initial press report, often sourced to people familiar with the matter, an unconfirmed price range, then a period in which the equity trades on deal probability rather than fundamentals until the company confirms, denies or declines to comment. The relevant mechanism here is valuation arbitrage on the stub: the parent typically trades at a discount to the implied sum of parts when a unit sale of this size is rumoured, and past episodes in IT services and business-process outsourcing have tended to re-rate the parent only when proceeds earmarking, debt paydown versus return of capital, is spelled out. The distinction that matters is strategic versus sponsor buyer: insurance software assets with recurring revenue have historically attracted private equity, and sponsor interest usually caps the multiple relative to what a strategic would pay for synergies. DXC has form here, having previously separated and divested units as part of a broader portfolio reshaping, so the pattern of monetising non-core assets is established rather than new. Worth watching is any confirmation from the company, the identity of bidders, and whether reports move from 'considering' to a signed process, since that is the point at which rumour premia have tended to either crystallise or unwind.